ChanRx Obtains New Financing Round

  • Feed Type
  • Date
    11/21/2011
  • Company Name
    ChanRx
  • Mailing Address
    Undisclosed Garfield Heights, OH 44105
  • Company Description
    The company is developing small molecule drugs to treat atrial fibrillation.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The company, a spin out of Cleveland-based ChanTest, will use the funding to further evaluate the safety and efficacy of its proprietary AFIB drug, vanoxerine.
  • M&A Terms
  • Venture Investor
    Sante Ventures

By posting a comment, you agree to our terms and conditions.